Top Growth Trends in the Cloning And Mutagenesis Market: Key Insights and Opportunities for 2025-2034
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What key factors are powering the surge in the cloning and mutagenesis market right now?
Over the last few years, the cloning and mutagenesis market has seen rapid expansion. It is projected to increase from $2.98 billion in 2024 to $3.56 billion in 2025, with a compound annual growth rate (CAGR) of 19.5%. Factors that have contributed to growth during the historical period include advancements in genetic studies, a growing need in the pharmaceutical research sector, the emergence of genetic engineering in agriculture, applications in biomedical research, and novel uses in molecular biology.
How fast Is the cloning and mutagenesis market expected to grow, and what’s its future value?
In the coming years, the cloning and mutagenesis market is set for swift expansion, with predictions suggesting it will reach the value of “$7.2 billion by 2029, boasting a compound annual growth rate (CAGR) of 19.3%. This growth during the forecast period is largely due to the increased use in gene therapy, a growing need for personalized medicine, advancements in functional genomics, breakthroughs in synthetic biology, and its application in agricultural biotechnology. Furthermore, the anticipated trends within the forecasted period include therapeutic targeted gene editing, improved precision, and specificity, customizable molecular instruments, wider applications within agriculture, and consideration for ethics and regulations.
Get your cloning and mutagenesis market report here!
https://www.thebusinessresearchcompany.com/report/cloning-and-mutagenesis-global-market-report
What are the leading drivers of growth in the cloning and mutagenesis market?
The cloning and mutagenesis market is forecasted to expand, driven by an increasing demand for genetically modified products. Genetically modified products are living organisms or substances that have been altered through genetic engineering to gain new features and traits. The process of cloning creates precise genetic copies of various living species that are resistant to insects and plants, and is also used in medical sciences for gene therapy. Hence, the upsurge in the demand for genetically modified products bolsters the growth of the cloning and mutagenesis market. For example, in February 2023, the Bayar AG annual report, issued by the German biotechnology and pharmaceutical company, revealed a notable growth in the yearly sales of the crop sciences and pharmaceutical segment, including genetically modified products, compared to 2021. Sales in the crop sciences segment escalated to $27,794.38 million in 2022 from $22,314.79 million in 2021. Consequently, the increased demand for genetically modified products is propelling the cloning and mutagenesis market.
What are the key segments defining the cloning and mutagenesis market?
The cloning and mutagenesis market covered in this report is segmented –
1) By Product: Cloning Kits, Mutagenesis Kits, Other Product
2) By Technique: Blunt End Cloning, Topo PCR Cloning, Seamless Cloning, Site-Directed Mutagenesis, Other Techniques
3) By End User: Academic and Research Institutes, Biotechnology Companies, Other End User
Subsegments:
1) By Cloning Kits: Bacterial Cloning Kits, Yeast Cloning Kits, Viral Cloning Kits, Plasmid Cloning Kits
2) By Mutagenesis Kits: Site-Directed Mutagenesis Kits, Random Mutagenesis Kits, Error-Prone PCR Kits, CRISPR Or Cas9 Mutagenesis Kits
3) By Other Products: Enzymes, Vector Systems, Accessories
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10541&type=smp
Who are the key players steering the development of the cloning and mutagenesis market?
Major companies operating in the cloning and mutagenesis market include Thermo Fisher Scientific, Takara Bio Inc., Agilent Technologies Inc., Jena Bioscience GmbH, Transgen Biotech Co, New England Biolabs, Merck KGaA, Promega Corporation, Bio-Rad Laboratories Inc., Danaher, Genomax Technologies Pte Ltd, GENEWIZ Inc., abm Inc., GenScript, EZBioscience, Codex DNA Inc., Aragen Life Sciences, Bio-Techne, Charles River Laboratories, Integrated DNA Technologies, MedGenome, Sino Biological Inc., BioChain Institute Inc., OriGene Technologies Inc., Creative Biogene, Bioneer Corporation, Synbio Technologies LLC, Lucigen Corporation, Biomatik Corporation, Quanta BioDesign Ltd., Inscripta Inc.
What emerging trends are influencing the growth of the cloning and mutagenesis market?
Top firms in the cloning and mutagenesis market are innovating advanced technologies like bacteriophage genome modifying technologies to gain a competitive advantage. These technologies involve methods and tools that intentionally change the genetic material of bacteriophages – viruses that infect bacteria, for different applications in research, therapy, or industry. For instance, in October 2022, iNtRON Biotechnology, a biotech firm based in South Korea, introduced its 2nd generation technology for Robot Bacteriophage. This technology utilizes random transposon mutagenesis, which allows for the alteration of the bacteriophage genome. Together with the previously developed customized CRISPR/Cas system, it can identify and eliminate non-essential genes in the bacteriophage genome. The firm aims to create and manufacture bacteriophages with specific characteristics freely, contributing to the creation of immunotherapeutic agents and antiviral solutions.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10541
Which regions are most influential in expanding the cloning and mutagenesis market?
North America was the largest region in the cloning and mutagenesis market in 2024.Asia-pacific is expected to be the fastest-growing region in the global cloning and mutagenesis market report during the forecast period. The regions covered in the cloning and mutagenesis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Browse Through More Similar Reports By The Business Research Company:
Generic Pharmaceuticals Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/generic-pharmaceuticals-global-market-report
General Dental Devices And Equipment Global Market Report 2024
Nucleic Acid Based Gene Therapy Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
